In this article, we will be taking a look at the 15 best biotech stocks to buy according to billionaires. Although biotech ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

The Wasatch U.S. Select Fund—Investor Class gained 0.24% but underperformed the benchmark Russell 3000® Growth Index, which ...

Discover why pharmaceutical-grade supplements command premium prices and whether their higher standards of purity, potency ...

Akeso's immunotherapy drug allowed half of its patients to go 11.1 months without their condition worsening Chinese drug ...

HC Wainwright reiterated their buy rating on shares of PDS Biotechnology (NASDAQ:PDSB – Free Report) in a report issued on Thursday,Benzinga reports. The firm currently has a $21.00 price target on ...

A biotechnology company whose goal is to bring back the wooly mammoth says its recent small step is big news. Colossal ...

The proposed initial public offering (IPO) comprises a fresh issue of equity worth Rs 190 crore, along with an offer-for-sale ...

It’s a tough job analysing share prices and company performance, especially in the middle of a sharp share market downturn, ...

Sun Pharmaceutical Industries, Inc., based in New Jersey, has recalled 9,840 bottles of Morphine Sulfate extended-release ...

The Netflix series "Dabba Cartel", currently trending within the top 10 most viewed in Bangladesh, attempts to carve out a ...

Pharmaceutical manufacturers are padding their wallets while rural families and retirees are squeezed by a system designed to benefit shareholders, not patients,” writes Tonja Hanson in an op-ed.